Intrexon reported $10.14M in Selling and Administration Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Agenus AGEN:US USD 18.1M 809K
Amgen AMGN:US USD 1.47B 181M
Anika Therapeutics ANIK:US USD 21.28M 8K
AstraZeneca AZN:LN USD 3.35B 280M
Bluebird Bio BLUE:US USD 33.4M 3.29M
Bristol Myers Squibb BMY:US USD 2.27B 336M
Gilead Sciences GILD:US USD 2.02B 807M
GlaxoSmithKline GSK:LN GBP 2.44B 467M
Heron Therapeutics HRTX:US USD 28.18M 3.94M
Immunogen IMGN:US USD 33.62M 9.83M
Intrexon XON:US USD 10.14M 2.53M
Karyopharm Therapeutics KPTI:US USD 34.64M 2.69M
Ligand Pharmaceuticals LGND:US USD 17.44M 2.86M
Macrogenics MGNX:US USD 15.35M 1.69M
Mannkind MNKD:US USD 22.64M 3.4M
Merk MRK:US USD 2.63B 134M
Novartis NOVN:VX USD 3.7B 295M
Peregrine Pharmaceuticals PPHM:US USD 6.83M 449K
Rigel Pharmaceuticals RIGL:US USD 25.9M 1.08M
Roche Holding ROG:VX 5.64B 899M
Sangamo Biosciences SGMO:US USD 16.24M 1.14M
Thermo Fisher Scientific TMO:US USD 1.84B 372M
Veracyte VCYT:US USD 42.73M 2.77M
Xencor XNCR:US USD 12.37M 1.28M
Ziopharm Oncology ZIOP:US USD 3.28M 147K